Importantly, the levels of infiltrated NK‐activated cells and NKG2D expression in HCC patients were both lower in the high‐risk group compared to the low‐risk group with the G1‐G2 stage. The gene discussed is KLRK1; the disease is hepatocellular carcinoma.